Dildora Nasretdinova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Dildora Nasretdinova has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Aziz Mominov
Tashkent State Medical University, Tashkent, Uzbekistan, Uzbekistan
1 shared publication - Lazzat Zhussupbekova
Department of Internal Diseases, Astana Medical University, Astana 010000, Kazakhstan
1 shared publication - Nargiza A. Khasanova
Department of Internal Diseases in Family Medicine №1 and Fundamentals of Preventive Medicine, Tashkent State Medical University, Tashkent, Uzbekistan, Uzbekistan
1 shared publication - Nargiza Nurillaeva
Toshkent tibbiyot akademiyasi
1 shared publication - Shoxista Kurbonova
Tashkent State Medical University, Tashkent, Uzbekistan, Uzbekistan
1 shared publication
Latest Publications
- Open Access
- 9 July 2026
- Published by MDPI AG in Preprints.org
Genetic Polymorphism of the FGB G-455A Gene in Patients with Ischemic Heart Disease of Uzbek Nationality
This study aimed to examine the distribution of allele and genotype frequencies of the β-fibrinogen -455G/A polymorphism among patients with ischemic heart disease (IHD) and to evaluate fibrinogen levels according to genotype. Materials and methods: A total of 135 patients with primarily stable angina pectoris were included, comprising 57 men and 78 women, hospitalised in the First Cardiology Department of the Multidisciplinary Clinic at Tashkent Medical University. The mean age was 58.0 ± 1.2 years (range: 42–66 years). The control group consisted of 40 apparently healthy individuals. Results: In the main group, genotype frequencies were G/G – 53.3%, G/A – 22.2%, and A/A – 24.4%. In the control group, the respective frequencies were 57.5%, 22.5%, and 20.0%. The lowest fibrinogen levels were found in G/G genotype carriers, while the highest were observed in A/A genotype carriers. Conclusion: Although allele frequencies were similar between groups, a marked genotype-dependent effect on fibrinogen levels was identified. These findings align with published evidence that the A allele is associated with increased fibrinogen synthesis and a more prothrombotic phenotype.
- 9 July 2026
- Published by MDPI AG in Preprints.org
Open AccessGenetic Polymorphism of the FGB G-455A Gene in Patients with Ischemic Heart Disease of Uzbek Nationality
This study aimed to examine the distribution of allele and genotype frequencies of the β-fibrinogen -455G/A polymorphism among patients with ischemic heart disease (IHD) and to evaluate fibrinogen levels according to genotype. Materials and methods: A total of 135 patients with primarily stable angina pectoris were included, comprising 57 men and 78 women, hospitalised in the First Cardiology Department of the Multidisciplinary Clinic at Tashkent Medical University. The mean age was 58.0 ± 1.2 years (range: 42–66 years). The control group consisted of 40 apparently healthy individuals. Results: In the main group, genotype frequencies were G/G – 53.3%, G/A – 22.2%, and A/A – 24.4%. In the control group, the respective frequencies were 57.5%, 22.5%, and 20.0%. The lowest fibrinogen levels were found in G/G genotype carriers, while the highest were observed in A/A genotype carriers. Conclusion: Although allele frequencies were similar between groups, a marked genotype-dependent effect on fibrinogen levels was identified. These findings align with published evidence that the A allele is associated with increased fibrinogen synthesis and a more prothrombotic phenotype.